Many finance professionals -- and not a few investors -- consider Walgreens a juicy target for private equity players. In ...

In recent trading, shares of Walgreens Boots Alliance Inc (Symbol: WBA) have crossed above the average analyst 12-month target price of $9.87, changing hands for $11.76/share. When a stock reaches ...

Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally. It operates through three segments: U ...

Until recently, many Walgreens Boots Alliance (NASDAQ: WBA) investors were desperately hungry for good news to boost the company's languishing stock price. On Dec. 10 they got some, in the form of ...

Walgreens Boots Alliance (WBA) is scheduled to report earnings on March 27, 2025. The last reported earnings were for reported on January 10, 2025 for Q1.

Financial giants have made a conspicuous bullish move on Walgreens Boots Alliance. Our analysis of options history for Walgreens Boots Alliance WBA revealed 10 unusual trades. Delving into the ...

Excluding items, Walgreens reported earnings of 51 cents per share in the first quarter, compared with analysts’ average estimate of 37 cents ...

Walgreens Boots Alliance, Inc. engages in the provision of healthcare and retail pharmacy services. It operates through the following segments: United States Retail Pharmacy, International, and ...

This page uses Cookies. For proper functioning of the page Cookies are needed. You agree to using Cookies by clicking "OK". More infos can be found in our Privacy declaration . If you disagree this ...

A Justice Department lawsuit alleges the illegal prescription-filling by Walgreens included opioids, and began in August 2012. Walgreens CEO Tim Wentworth admitted in a recent fiscal report call ...